Platform
Features
1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Employees
Links
3 members
2 members
Calico
6 followers
Neuron23
Thermo Fisher Scientific
166 followers
Genentech
150 followers
Biogen
114 followers
Illumina
67 followers
Agilent Technologies
63 followers
Avantor
10 followers
Promega
8 followers
United Therapeutics
7 followers
Sage Therapeutics
5 followers
Explore companies